InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,010.03
(
0.24%
)
US TECH 100
20,540.40
(
-0.12%
)
Dow Jones
44,345.48
(
0.81%
)
Brent Oil
71.69
(
-2.73%
)
Bitcoin
84,330.78
(
4.79%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DonShimoda post# 23200

Monday, 10/22/2012 12:19:34 PM

Monday, October 22, 2012 12:19:34 PM

Post# of 80490
>GIST represents a potentially significant incremental revenue opportunity for the company

Agreed. In a footnote in the Ariad slides they say 30% of Gleevec sales is for GIST. A decent chance Pona is best-in-class for GIST - potentially a similar sized market as CML for pona.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up